Preliminary Results of Bioactive Amniotic Suspension with Allograft for Achieving One and Two-Level Lumbar Interbody Fusion.

about

Preliminary Results of Bioactive Amniotic Suspension with Allograft for Achieving One and Two-Level Lumbar Interbody Fusion.

Item

http://www.wikidata.org/entity/Q36856376

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Preliminary Results of Bioacti ...... Level Lumbar Interbody Fusion.

@en

type

Item

label

Preliminary Results of Bioacti ...... Level Lumbar Interbody Fusion.

@en

prefLabel

Preliminary Results of Bioacti ...... Level Lumbar Interbody Fusion.

@en

P1476

Preliminary Results of Bioacti ...... Level Lumbar Interbody Fusion.

@en

P2093

Brian McManus

http://www.w3.org/2001/XMLSchema#string

David A Cavanaugh

http://www.w3.org/2001/XMLSchema#string

Devan Moody

http://www.w3.org/2001/XMLSchema#string

Eubulus J Kerr

http://www.w3.org/2001/XMLSchema#string

Kelly A Frank

http://www.w3.org/2001/XMLSchema#string

Marcus B Stone

http://www.w3.org/2001/XMLSchema#string

Philip A Utter

http://www.w3.org/2001/XMLSchema#string

Pierce D Nunley

http://www.w3.org/2001/XMLSchema#string

P2860

Smoking as a predictor of negative outcome in lumbar spinal fusion

Iliac crest bone graft harvest donor site morbidity. A statistical evaluation

Prospective analysis of a new bone graft in lumbar interbody fusion: results of a 2- year prospective clinical and radiological study

Allogeneic morphogenetic protein vs. recombinant human bone morphogenetic protein-2 in lumbar interbody fusion procedures: a radiographic and economic analysis

Safety and effectiveness of recombinant human bone morphogenetic protein-2 for spinal fusion: a meta-analysis of individual-participant data.

A comprehensive assessment of the risk of bone morphogenetic protein use in spinal fusion surgery and postoperative cancer diagnosis.

Minimum acceptable outcomes after lumbar spinal fusion.

Symposium: a critical discrepancy-a criteria of successful arthrodesis following interbody spinal fusions.

Bone healing and spinal fusion.

Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion.

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.14444/3012

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27162714

http://www.w3.org/2001/XMLSchema#string

P932

4852597

http://www.w3.org/2001/XMLSchema#string